Sei Investments Co. lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 25.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 218,696 shares of the company's stock after selling 74,969 shares during the period. Sei Investments Co. owned about 0.13% of Option Care Health worth $5,074,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the stock. UMB Bank n.a. boosted its holdings in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after acquiring an additional 1,005 shares during the period. Quarry LP boosted its stake in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after acquiring an additional 2,628 shares in the last quarter. Blue Trust Inc. grew its position in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after acquiring an additional 681 shares during the period. Finally, Venturi Wealth Management LLC increased its stake in shares of Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after purchasing an additional 4,561 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
OPCH has been the topic of several research analyst reports. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Barrington Research boosted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.
View Our Latest Research Report on Option Care Health
Insider Activity
In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.64% of the company's stock.
Option Care Health Trading Down 4.0 %
Option Care Health stock traded down $1.40 during midday trading on Friday, hitting $33.54. 2,392,435 shares of the stock were exchanged, compared to its average volume of 1,734,150. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.51 billion, a price-to-earnings ratio of 28.18, a PEG ratio of 2.30 and a beta of 1.07. The stock's 50-day simple moving average is $32.97 and its 200 day simple moving average is $28.49. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.